Cargando…
PET imaging of noradrenaline transporters in Parkinson’s disease: focus on scan time
OBJECTIVE: In subjects with idiopathic Parkinson’s disease (PD) the functional state of the locus coeruleus and the subtle derangements in the finely tuned dopamine–noradrenaline interplay are largely unknown. The PET ligand (S,S)-[(11)C]-O-methylreboxetine (C-11 MRB) has been described to reliably...
Autores principales: | Brumberg, Joachim, Tran-Gia, Johannes, Lapa, Constantin, Isaias, Ioannis U., Samnick, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373329/ https://www.ncbi.nlm.nih.gov/pubmed/30293197 http://dx.doi.org/10.1007/s12149-018-1305-5 |
Ejemplares similares
-
Differential diagnosis of parkinsonism: a head-to-head comparison of FDG PET and MIBG scintigraphy
por: Brumberg, Joachim, et al.
Publicado: (2020) -
Noradrenaline transporter PET reflects neurotoxin-induced noradrenaline level decrease in the rat hippocampus
por: Sakai, Takayuki, et al.
Publicado: (2023) -
Noradrenaline and Parkinson's Disease
por: Delaville, Claire, et al.
Publicado: (2011) -
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
por: Hartrampf, Philipp E., et al.
Publicado: (2020) -
Brain metabolic alterations herald falls in patients with Parkinson’s disease
por: Isaias, Ioannis U., et al.
Publicado: (2020)